WO2007108001A3 - Remodelage de ligament - Google Patents
Remodelage de ligament Download PDFInfo
- Publication number
- WO2007108001A3 WO2007108001A3 PCT/IL2007/000378 IL2007000378W WO2007108001A3 WO 2007108001 A3 WO2007108001 A3 WO 2007108001A3 IL 2007000378 W IL2007000378 W IL 2007000378W WO 2007108001 A3 WO2007108001 A3 WO 2007108001A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- remodeling
- ligament remodeling
- ligament
- conforms
- diluents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0078—Ultrasound therapy with multiple treatment transducers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Electromagnetism (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une composition pharmaceutique comprenant un principe actif incluant une quantité physiologiquement efficace d'un agent de remodelage capable de modifier les propriétés d'un ligament jaune (LF), de telle sorte que le LF se conforme à une dimension disponible d'un canal de l'épendyme; l'invention concerne également un vecteur pharmaceutiquement acceptable, des diluants et des excipients.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78456106P | 2006-03-22 | 2006-03-22 | |
| US60/784,561 | 2006-03-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007108001A2 WO2007108001A2 (fr) | 2007-09-27 |
| WO2007108001A3 true WO2007108001A3 (fr) | 2007-12-06 |
Family
ID=38481926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IL2007/000378 Ceased WO2007108001A2 (fr) | 2006-03-22 | 2007-03-22 | Remodelage de ligament |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2007108001A2 (fr) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037296A1 (fr) * | 1998-01-23 | 1999-07-29 | Warner-Lambert Company | Gabapentine et ses derives pour le traitement de la douleur musculaire et squelettique |
| US6684886B1 (en) * | 2000-01-21 | 2004-02-03 | Prospine, Inc. | Intervertebral disc repair methods and apparatus |
| JP2004331612A (ja) * | 2003-05-09 | 2004-11-25 | Koyo Chemical Kk | 腰部脊柱管狭窄症による間歇跛行改善剤 |
| WO2006044727A2 (fr) * | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Dispositifs et procedes d'ablation de tissus |
-
2007
- 2007-03-22 WO PCT/IL2007/000378 patent/WO2007108001A2/fr not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037296A1 (fr) * | 1998-01-23 | 1999-07-29 | Warner-Lambert Company | Gabapentine et ses derives pour le traitement de la douleur musculaire et squelettique |
| US6684886B1 (en) * | 2000-01-21 | 2004-02-03 | Prospine, Inc. | Intervertebral disc repair methods and apparatus |
| JP2004331612A (ja) * | 2003-05-09 | 2004-11-25 | Koyo Chemical Kk | 腰部脊柱管狭窄症による間歇跛行改善剤 |
| WO2006044727A2 (fr) * | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Dispositifs et procedes d'ablation de tissus |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE WPI Week 200481, Derwent World Patents Index; AN 2004-817460, XP002453291 * |
| KIMURA S ET AL: "Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain reliefin relief in degenerative lumbar diseases", PAIN, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 92, no. 3, 2001, pages 363 - 371, XP002975869, ISSN: 0304-3959 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007108001A2 (fr) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003038A (es) | Derivados de quinazolinona 5-sustituidos como agentes antitumorales. | |
| IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
| WO2006096434A3 (fr) | Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete | |
| WO2007027527A3 (fr) | Composes d'isoindole-imide et compositions renfermant ceux-ci et procedes d'utilisation de ceux-ci | |
| TWI366460B (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
| MX2009004861A (es) | Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa. | |
| SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
| JO2973B1 (en) | Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol | |
| UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
| WO2008136392A1 (fr) | Préparation pour une administration orale | |
| EP2316420A8 (fr) | Procédé pour réduire la douleur | |
| WO2008128191A3 (fr) | Formes dosifiees orales de cephalotaxine | |
| WO2008008882A3 (fr) | Modulateur du récepteur des glucocorticoïdes et procédés d'utilisation | |
| WO2008004100A3 (fr) | Composés thérapeutiques | |
| WO2010029093A3 (fr) | Compositions destinées à une administration percutanée | |
| WO2006076097A3 (fr) | Preparation non cristalline stable contenant du losartan | |
| WO2007009691A3 (fr) | Combinaison de substances active s | |
| MX2009005329A (es) | Composiciones farmaceuticas anticonvulsivas. | |
| MY144613A (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same | |
| UA95274C2 (ru) | Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления | |
| WO2009108017A3 (fr) | Nouveaux dérivés de pyruvate avec effet neuroprotecteur, processus de préparation de ceux-ci et composition pharmaceutique comprenant ces dérivés | |
| WO2007108001A3 (fr) | Remodelage de ligament | |
| WO2005120518A3 (fr) | Utilisation d'analogues d'atp pour le traitement des maladies cardio-vasculaires | |
| AU2016219606A1 (en) | Pharmaceutical composition for treating or preventing burn injuries | |
| WO2007047881A3 (fr) | Methode de traitement de la douleur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07713394 Country of ref document: EP Kind code of ref document: A2 |